Search research articles
Contact Us
Filters
Showing results (21-30 of 200) with videos related to
Page
of 20
Sort By:
Atherosclerosis
|
November 26, 2009
Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives
Roberta Baetta, Alberto Corsini
Pharmacological Research
|
February 20, 2014
Clinical evidence of statin therapy in non-dyslipidemic disorders
Nicola Ferri, Alberto Corsini
Expert Review of Clinical Pharmacology
|
January 14, 2014
Drug-drug interaction with statins
Alberto Corsini, Stefano Bellosta
Expert Opinion on Drug Metabolism & Toxicology
|
September 10, 2024
Drug interactions in cardiology: focus on statins and their combination with other lipid-lowering drugs
Stefano Bellosta, Alberto Corsini
Vascular Health and Risk Management
|
December 15, 2007
Are pleiotropic effects of statins real?
Alberto Corsini, Nicola Ferri, Michele Cortellaro
Minerva Medica
|
March 22, 2022
Artichoke and bergamot extracts: a new opportunity for the management of dyslipidemia and related risk factors
Lorenzo Arnaboldi, Alberto Corsini, Stefano Bellosta
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
April 24, 2023
Hypocholesterolaemic treatment in coronary unit: from statins to anti PCSK9 therapies and bempedoic acid
Nicola Ferri, Alberto Corsini, Massimiliano Ruscica
Hematology Reports
|
March 27, 2024
Drug-Drug Interactions of FXI Inhibitors: Clinical Relevance
Nicola Ferri, Elisa Colombo, Alberto Corsini
Pharmaceutics
|
November 27, 2024
Bempedoic Acid, the First-in-Class Oral ATP Citrate Lyase Inhibitor with Hypocholesterolemic Activity: Clinical Pharmacology and Drug-Drug Interactions
Nicola Ferri, Elisa Colombo, Alberto Corsini
Atherosclerosis. Supplements
|
June 5, 2002
Pharmacological interactions of statins
Rodolfo Paoletti, Alberto Corsini, Stefano Bellosta
Page
of 20
Search research articles
Search
Showing results (21-30 of 200) with videos related to
Sort By:
Page
of 20
Atherosclerosis
|
November 26, 2009
Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives
Roberta Baetta, Alberto Corsini
Pharmacological Research
|
February 20, 2014
Clinical evidence of statin therapy in non-dyslipidemic disorders
Nicola Ferri, Alberto Corsini
Expert Review of Clinical Pharmacology
|
January 14, 2014
Drug-drug interaction with statins
Alberto Corsini, Stefano Bellosta
Expert Opinion on Drug Metabolism & Toxicology
|
September 10, 2024
Drug interactions in cardiology: focus on statins and their combination with other lipid-lowering drugs
Stefano Bellosta, Alberto Corsini
Vascular Health and Risk Management
|
December 15, 2007
Are pleiotropic effects of statins real?
Alberto Corsini, Nicola Ferri, Michele Cortellaro
Minerva Medica
|
March 22, 2022
Artichoke and bergamot extracts: a new opportunity for the management of dyslipidemia and related risk factors
Lorenzo Arnaboldi, Alberto Corsini, Stefano Bellosta
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
April 24, 2023
Hypocholesterolaemic treatment in coronary unit: from statins to anti PCSK9 therapies and bempedoic acid
Nicola Ferri, Alberto Corsini, Massimiliano Ruscica
Hematology Reports
|
March 27, 2024
Drug-Drug Interactions of FXI Inhibitors: Clinical Relevance
Nicola Ferri, Elisa Colombo, Alberto Corsini
Pharmaceutics
|
November 27, 2024
Bempedoic Acid, the First-in-Class Oral ATP Citrate Lyase Inhibitor with Hypocholesterolemic Activity: Clinical Pharmacology and Drug-Drug Interactions
Nicola Ferri, Elisa Colombo, Alberto Corsini
Atherosclerosis. Supplements
|
June 5, 2002
Pharmacological interactions of statins
Rodolfo Paoletti, Alberto Corsini, Stefano Bellosta
Page
of 20